Latest News

COVID-19 outbreak hits research station in Antarctica


 

A COVID-19 outbreak has occurred at one of the most remote places on earth – the Princess Elisabeth Polar Station in Antarctica.

Two-thirds of the 25 workers have tested positive at the station, despite all of them being fully vaccinated and going through several testing stages before being allowed entrance, the Belgium publication Le Soir reported.

So far, all the cases are mild at the station, which is owned by Belgium and operated by a private group: the International Polar Foundation.

The first case was discovered Dec. 14 among a group that arrived a week earlier in Antarctica, Le Soir reported. The first three people to test positive evacuated Dec. 23, Le Soir said, but the virus continued to spread among the remaining workers at the base.

Le Soir, citing a virologist, said the Omicron variant probably caused the outbreak, because the crew made its last stop in South Africa before arriving in Antarctica.

New arrivals to the station have been put on hold until the outbreak is brought under control, and one of the missions planned for the base has been postponed, Le Soir said.

“The situation isn’t dramatic,” Joseph Cheek, a project manager for the International Polar Foundation, told the BBC. “While it has been an inconvenience to have to quarantine certain members of the staff who caught the virus, it hasn’t significantly affected our work at the station overall.”

The BBC said there was another COVID outbreak in Antarctica about a year ago at the Bernardo O’Higgins research station operated by Chile.

A version of this article first appeared on WebMD.com.

Recommended Reading

Influenza tied to long-term increased risk for Parkinson’s disease
MDedge Neurology
Expected spike in acute flaccid myelitis did not occur in 2020
MDedge Neurology
FDA authorizes COVID boosters for all U.S. adults
MDedge Neurology
Specialists think it’s up to the PCP to recommend flu vaccines. But many patients don’t see a PCP every year
MDedge Neurology
AHA challenges diet doctor’s study alleging COVID vax risks
MDedge Neurology
New data on rare myocarditis after COVID-19 vaccination
MDedge Neurology
Risk for severe COVID-19 and death plummets with Pfizer booster
MDedge Neurology
COVID-19 asymptomatic infection rate remains high
MDedge Neurology
COVID cases spike as questions remain about Omicron’s threat
MDedge Neurology
FDA backs Pfizer booster for 12- to 15-year-olds
MDedge Neurology